Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Minnesota Medicine|November 19, 2003
The state of the clinical trials system todayStephen L Kopecky, Terry Jopke
Current Cardiology Reports|August 6, 2017
Cholesterol Management in the Era of PCSK9 InhibitorsAnna Svatikova, Stephen L Kopecky
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Therapeutic potential of monoclonal antibodies in myocardial reperfusion injuryAnil Nigam, Stephen L Kopecky
The CLAO Journal : Official Publication of the Contact Lens Association of Ophthalmologists, Inc|July 1, 1992
Fitting the SoftPerm contact lens after keratoplastyP S Binder, L Kopecky
The American Journal of Cardiology|November 20, 2019
Characteristics and Outcomes of Patients Treated With Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (The Mayo Clinic Experience)Ohad Oren, Erica L Kludtke, Stephen L Kopecky
Cardiology in Review|September 7, 2002
Effect of early statin therapy after acute coronary syndromes: a concise review of the recent dataKevin A Bybee, R Scott Wright, Stephen L Kopecky
The American Journal of Cardiology|July 30, 2013
Questions and answers on proper peri-operative management of antiplatelet therapy after coronary stent implantation to prevent stent thrombosisAmmar M Killu, R Scott Wright, Stephen L Kopecky
Mayo Clinic Proceedings|November 15, 2000
Update on intravenous fibrinolytic therapy for acute myocardial infarctionR S Wright, S L Kopecky, G S Reeder
Pageof 12